ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Carcinoma
Endometrial Cancer
Fallopian Tube Cancer
Breast Cancer
Triple Negative Breast Cancer

Ovarian Cancer trials near Houston, TX, USA:

Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

To develop a shared decision-making (SDM) tool to help Spanish-speaking patients make decisions about their maintenance therapy

Enrolling
Ovarian Cancer
Behavioral: Engaging Patients in Decision Making
Other: Shared Medical Decision Tool
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

To learn if adding lurbinectedin to the combination of paclitaxel and bevacizumab can help to control advanced cancer....

Enrolling
Ovarian Cancer
Drug: Lurbinectedin
Drug: Bevacizumab

Phase 1

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2

Verastem

The Woodlands, Texas, United States and 46 other locations

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Enrolling
Fallopian Tube Cancer
Ovarian Cancer
Drug: Pembrolizumab
Drug: ONC-392

Phase 2

OncoC4

The Woodlands, Texas, United States and 20 other locations

To learn if adding etigilimab to nivolumab therapy can help to control clear cell ovarian, fallopian tube, and primary peritoneal cancers...

Enrolling
Ovarian Cancer
Drug: Nivolumab
Drug: Etigilimab

Phase 2

M.D. Anderson Cancer Center
M.D. Anderson Cancer Center

Houston, Texas, United States

and potential activity of a single intravenous (IV) dose of SynKIR-110 administered to subjects with mesothelin-expressing advanced ovarian ...

Enrolling
Ovarian Cancer
Cholangiocarcinoma Recurrent
Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR

Phase 1

Verismo Therapeutics

Houston, Texas, United States and 2 other locations

This is a multi-center, open-label phase 1 dose escalation trial that uses a modified 3+3 design to identify a recommended phase 2 dose (RP2D) of AB-...

Enrolling
Ovarian Neoplasms
Carcinoma, Ovarian Epithelial
Biological: AB-1015

Phase 1

ArsenalBio

Houston, Texas, United States and 9 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

The Woodlands, Texas, United States and 27 other locations

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....

Active, not recruiting
Advanced Ovarian Cancer
FIGO Stage III-IV
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Houston, Texas, United States and 176 other locations

A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer...

Enrolling
Primary Peritoneal Cancer
Epithelial Ovarian Cancer
Drug: Luveltamab tazevibulin
Drug: Pegfilgrastim

Phase 2, Phase 3

Sutro Biopharma

The Woodlands, Texas, United States and 37 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems